Home NDC 67877-276-05 CLOPIDOGREL
Product NDC 67877-276
Requested package NDC 67877-276-05
11-digit product format 678770276
Labeler code 67877
Product ID 67877-276_04c45152-3a50-45e1-9edb-2ddf3ed43988
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name CLOPIDOGREL BISULFATE
Dosage form TABLET
Route ORAL
Labeler Ascend Laboratories, LLC
Application ANDA203632
Marketing category ANDA
Marketing start 2024-05-16
Substance CLOPIDOGREL BISULFATE
Active strength 75 mg/1
Pharmacologic classes Cytochrome P450 2C8 Inhibitors [MoA], Decreased Platelet Aggregation [PE], P2Y12 Platelet Inhibitor [EPC], P2Y12 Receptor Antagonists [MoA]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A203632-001 CLOPIDOGREL BISULFATE CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A203632-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 1c564ffb4f44…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A203632-001 CLOPIDOGREL BISULFATE EQ 75MG BASE TABLET / ORAL AB 2023-12-08 a50c72e98297…
Observed Orange Book normalized TE history# openFDA label cross-check# Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
Matched openFDA labels page 1 of 1 · 4 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join CLOPIDOGREL CLOPIDOGREL BISULFATE Ascend Laboratories, LLC db1161c9-6efd-4361-a766-6a37c241ccee 2026-06-01 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 203632 application number: ANDA203632 ndc (package): 67877-276-05 ndc (product): 67877-276 ndc11 (package): 67877027605 CLOPIDOGREL CLOPIDOGREL BISULFATE REMEDYREPACK INC. 669f0bc6-f173-484d-8efe-c006683b25d1 2025-06-27 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 203632 application number: ANDA203632 CLOPIDOGREL CLOPIDOGREL BISULFATE A-S Medication Solutions ffeb2fca-d475-4d93-913d-0048ff9fcee9 2024-12-06 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 203632 application number: ANDA203632 CLOPIDOGREL CLOPIDOGREL BISULFATE A-S Medication Solutions 2564e8ee-fa2d-49d1-9a1a-6f3eb1e74032 2024-12-06 Boxed warning, Warnings, Adverse reactions Exact identifier application applno (ANDA): 203632 application number: ANDA203632
Additional Listing Data#
Finished product Yes
Brand name base CLOPIDOGREL
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength CLOPIDOGREL BISULFATE 75 mg/1
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 08I79HTP27 Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 309362 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 67877-276-05 CLOPIDOGREL 500 in 1 BOTTLE TABLET 500 8 67877-276-30 CLOPIDOGREL 30 in 1 BOTTLE TABLET 30 8 67877-276-90 CLOPIDOGREL 90 in 1 BOTTLE TABLET 90 8
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 67877-276 CLOPIDOGREL (CLOPIDOGREL BISULFATE) TABLET [ASCEND LABORATORIES, LLC] 8 Current NDC, 3 package rows 20240518_db1161c9-6efd-4361-a766-6a37c241ccee.zip
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 67877-276-05 67877027605 500 TABLET in 1 BOTTLE (67877-276-05) 500 tablet 2024-05-16 No No Current